These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Direct comparison of Tc-99m DTPA and Tc-99m HMPAO for evaluating brain death. Spieth ME, Ansari AN, Kawada TK, Kimura RL, Siegel ME. Clin Nucl Med; 1994 Oct; 19(10):867-72. PubMed ID: 7805319 [Abstract] [Full Text] [Related]
6. Tc-99m HMPAO SPECT imaging of the central nervous system in tuberous sclerosis. Sieg KG, Harty JR, Simmons M, Preston DF, Erickson HM. Clin Nucl Med; 1991 Sep; 16(9):665-7. PubMed ID: 1934829 [Abstract] [Full Text] [Related]
7. The diagnosis of brain death with Tc-99m HMPAO. Wilson K, Gordon L, Selby JB. Clin Nucl Med; 1993 May; 18(5):428-34. PubMed ID: 8508581 [Abstract] [Full Text] [Related]
9. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Inoue K, Nakagawa M, Goto R, Kinomura S, Sato T, Sato K, Fukuda H. Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088 [Abstract] [Full Text] [Related]
10. Tc-99m HMPAO SPECT of the brain in the neonate. Fockele DS, Baumann RJ, Shih WJ, Ryo UY. Clin Nucl Med; 1990 Mar; 15(3):175-7. PubMed ID: 2317998 [Abstract] [Full Text] [Related]
11. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H. J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207 [Abstract] [Full Text] [Related]
12. Increased brain retention of Tc-99m HMPAO following acetazolamide administration. Burt RW, Witt RM, Cikrit D, Carter J. Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809 [Abstract] [Full Text] [Related]